Report - Endpoints in HAP/VAP trials: Mortality, Clinical Endpoints ... · Hospital-acquired MRSA Pneumonia . 50 60 70 80 90 100 4 9 14 19 24 29. Days After Diagnosis. Survival (%) Linezolid

Please pass captcha verification before submit form